These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25996063)

  • 1. What is the mechanism of action of praziquantel and how might resistance strike?
    Cupit PM; Cunningham C
    Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research progress of the evaluation methods on the resistance of schistosome to praziquantel].
    Guo J; Guo JG
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):182-4. PubMed ID: 16300016
    [No Abstract]   [Full Text] [Related]  

  • 3. Praziquantel: do we need another antischistosoma treatment?
    Fenwick A
    Future Med Chem; 2015; 7(6):677-80. PubMed ID: 25996058
    [No Abstract]   [Full Text] [Related]  

  • 4. Schistosomiasis and its treatment.
    Caffrey CR
    Future Med Chem; 2015; 7(6):675-6. PubMed ID: 25996057
    [No Abstract]   [Full Text] [Related]  

  • 5. Something old, something new: is praziquantel enough for schistosomiasis control?
    Secor WE; Montgomery SP
    Future Med Chem; 2015; 7(6):681-4. PubMed ID: 25996059
    [No Abstract]   [Full Text] [Related]  

  • 6. Using an open source model to accelerate schistosomiasis drug research.
    Todd MH; Coaker H
    Future Med Chem; 2015; 7(6):689-92. PubMed ID: 25996061
    [No Abstract]   [Full Text] [Related]  

  • 7. The Journey to Discovering a Flatworm Target of Praziquantel: A Long TRP.
    Park SK; Marchant JS
    Trends Parasitol; 2020 Feb; 36(2):182-194. PubMed ID: 31787521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility or resistance of praziquantel in human schistosomiasis: a review.
    Wang W; Wang L; Liang YS
    Parasitol Res; 2012 Nov; 111(5):1871-7. PubMed ID: 23052781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery: schistosome treatment.
    Shadan S
    Nature; 2008 Mar; 452(7185):296. PubMed ID: 18354470
    [No Abstract]   [Full Text] [Related]  

  • 10. Decades down the line: the viability of praziquantel for future schistosomiasis treatment.
    Cioli D; Basso A; Valle C; Pica-Mattoccia L
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):835-7. PubMed ID: 23030319
    [No Abstract]   [Full Text] [Related]  

  • 11. Schistosomiasis control: praziquantel forever?
    Cioli D; Pica-Mattoccia L; Basso A; Guidi A
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field evaluation of a test for praziquantel resistance in Schistosoma sp.
    Kenworthy JD; Ye P; Wu GC; Yu H; Shi YJ; Li H; Coles GC
    Vet Parasitol; 2003 Apr; 113(1):83-7. PubMed ID: 12651219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.
    Doenhoff MJ; Pica-Mattoccia L
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):199-210. PubMed ID: 16597202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: is actin the praziquantel receptor?
    Tallima H; El Ridi R
    Int J Antimicrob Agents; 2007 Dec; 30(6):566-7. PubMed ID: 17900872
    [No Abstract]   [Full Text] [Related]  

  • 15. Praziquantel and the control of schistosomiasis.
    Doenhoff M; Kimani G; Cioli D
    Parasitol Today; 2000 Sep; 16(9):364-6. PubMed ID: 10951592
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
    Bergquist R; Utzinger J; Keiser J
    Infect Dis Poverty; 2017 Mar; 6(1):74. PubMed ID: 28351414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
    Doenhoff MJ; Cioli D; Utzinger J
    Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insight into praziquantel against various developmental stages of schistosomes.
    Wu W; Wang W; Huang YX
    Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of repeated praziquantel treatment on schistosomiasis mekongi morbidity as detected by ultrasonography.
    Chigusa Y; Ohmae H; Otake H; Keang H; Sinuon M; Saem C; Socheat D; Matsuda H
    Parasitol Int; 2006 Dec; 55(4):261-5. PubMed ID: 16893676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study progress on the mode of action of praziquantel against schistosomes].
    Xiao SH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Dec; 25(6):492-502. PubMed ID: 18441900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.